We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
-19.67%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$2.74B
AUM Growth
-$52.2M
Cap. Flow
+$616M
Cap. Flow %
22.46%
Top 10 Hldgs %
20.88%
Holding
327
New
27
Increased
203
Reduced
54
Closed
34

Top Buys

Rank Stock Value
1
MYGN icon
Myriad Genetics
MYGN
+$28.8M
2
WW
WW International
WW
+$26.6M
3
WIX icon
WIX.com
WIX
+$21.1M
4
PINC
Premier
PINC
+$20.4M
5
URBN icon
Urban Outfitters
URBN
+$19.1M

Sector Composition

Rank Sector Weight
1 Healthcare 22.84%
2 Industrials 19.01%
3 Technology 16.97%
4 Consumer Discretionary 11%
5 Communication Services 8.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VSM
176
DELISTED
Versum Materials, Inc.
VSM
$1.88M 0.07%
+67,913
New +$2.15M
CDW icon
177
CDW
CDW
$17B
$1.88M 0.07%
23,194
-286
-1% -$24.6K
MLAB icon
178
Mesa Laboratories
MLAB
$574M
$1.87M 0.07%
8,981
+845
+10% +$165K
EEFT icon
179
Euronet Worldwide
EEFT
$2.7B
$1.86M 0.07%
18,201
-566
-3% -$62.7K
CBZ icon
180
CBIZ
CBZ
$2.96B
$1.86M 0.07%
94,487
+9,225
+11% +$197K
LASR icon
181
nLIGHT
LASR
$3.17B
$1.83M 0.07%
103,209
+35,954
+53% +$681K
HUBB icon
182
Hubbell
HUBB
$27.2B
$1.83M 0.07%
18,421
-812
-4% -$89.1K
LMAT icon
183
LeMaitre Vascular
LMAT
$1.86B
$1.83M 0.07%
77,305
+30,174
+64% +$824K
NEO icon
184
NeoGenomics
NEO
$2.13B
$1.82M 0.07%
144,475
-53,829
-27% -$802K
LFCR icon
185
Lifecore Biomedical
LFCR
$190M
$1.81M 0.07%
152,885
+46,969
+44% +$645K
QCOM icon
186
Qualcomm
QCOM
$176B
$1.81M 0.07%
31,766
RGP icon
187
Resources Connection
RGP
$145M
$1.8M 0.07%
126,811
+12,375
+11% +$200K
KE
188
Kimball Electronics
KE
$628M
$1.8M 0.07%
115,956
+11,953
+11% +$210K
LNTH icon
189
Lantheus
LNTH
$6.59B
$1.78M 0.07%
113,971
+34,588
+44% +$530K
IIN
190
DELISTED
IntriCon Corporation
IIN
$1.77M 0.06%
+67,233
New +$2.56M
FARM
191
DELISTED
Farmer Brothers
FARM
$1.77M 0.06%
76,017
+18,446
+32% +$446K
RHI icon
192
Robert Half
RHI
$4.37B
$1.74M 0.06%
30,339
+7,104
+31% +$436K
SILC icon
193
Silicom
SILC
$242M
$1.73M 0.06%
49,447
+4,901
+11% +$191K
VCRA
194
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$1.72M 0.06%
43,819
-10,389
-19% -$376K
AIR icon
195
AAR Corp
AIR
$5.76B
$1.71M 0.06%
45,786
+4,368
+11% +$191K
DOV icon
196
Dover
DOV
$28.4B
$1.7M 0.06%
23,980
+1,134
+5% +$92.6K
SEI
197
Solaris Energy Infrastructure
SEI
$3.82B
$1.69M 0.06%
139,436
+13,485
+11% +$192K
BRK.B icon
198
Berkshire Hathaway Class B
BRK.B
$1.13T
$1.68M 0.06%
8,235
-6,896
-46% -$1.44M
CSII
199
DELISTED
Cardiovascular Systems, Inc.
CSII
$1.68M 0.06%
+58,898
New +$1.87M
CLAR icon
200
Clarus
CLAR
$143M
$1.67M 0.06%
165,273
-106,267
-39% -$1.11M

Similar funds

Rice Hall James & Associates's Q4 2018 Portfolio in Review

As of Q4 2018, Rice Hall James & Associates held 327 positions worth $2.74B, down 1.9% from $2.79B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Rice Hall James & Associates deployed $616M of net new capital in Q4 2018, opening 27 new positions and adding to 203 existing holdings. Its largest new stake was Myriad Genetics: 800,553 shares worth $23.3M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Coherent, an estimated $12.2M trimmed.

  • Rice Hall James & Associates's largest Q4 2018 buy was Myriad Genetics: 800,553 shares worth $23.3M.
  • Rice Hall James & Associates added most to WW International in Q4 2018, an estimated $26.6M increase.
  • Rice Hall James & Associates's biggest Q4 2018 reduction was Coherent, cutting an estimated $12.2M.
  • Rice Hall James & Associates fully exited Conduent in Q4 2018, selling an estimated $25.1M.
  • Rice Hall James & Associates's ten largest holdings make up 21% of its $2.74B portfolio in Q4 2018.
  • Rice Hall James & Associates opened 27 new positions and closed 34 in Q4 2018.
  • Rice Hall James & Associates's portfolio value fell 1.9% quarter-over-quarter to $2.74B.

Based on Rice Hall James & Associates's 13F filing for Q4 2018, filed 14 Feb 2019.